Clinical Trial Update: Exploratory Clinical Study on the Safety and Efficacy of Targeted BCMA Autologous CART Cell Injection in Subjects With Recurrent/Refractory Light Chain Amyloidosis [NA]

View source ↗

Summary

An exploratory clinical study is evaluating the safety and potential efficacy of BCMA-targeted autologous CAR T cell injections in patients with recurrent or re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Light-chain Amyloidosis

Drugs mentioned

• BCMA-targeted autologous CAR T cell therapy

Snippet

Sponsor: Beijing Boren Hospital | Conditions: Light Chain Amyloidosis | NA | Status: RECRUITING